NDC 0378-2721

Galantamine

Galantamine

Galantamine is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Galantamine Hydrobromide.

Product ID0378-2721_8ef24417-c577-412c-80fe-06a747cbd70f
NDC0378-2721
Product TypeHuman Prescription Drug
Proprietary NameGalantamine
Generic NameGalantamine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2008-08-29
Marketing End Date2019-12-31
Marketing CategoryANDA / ANDA
Application NumberANDA077590
Labeler NameMylan Pharmaceuticals Inc.
Substance NameGALANTAMINE HYDROBROMIDE
Active Ingredient Strength4 mg/1
Pharm ClassesCholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC Exclude FlagN

Packaging

NDC 0378-2721-91

60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2721-91)
Marketing Start Date2008-08-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0378-2721-91 [00378272191]

Galantamine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077590
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2008-08-29
Marketing End Date2019-12-31

NDC 0378-2721-05 [00378272105]

Galantamine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077590
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-08-29
Marketing End Date2016-06-13

Drug Details

Pharmacological Class

  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]

NDC Crossover Matching brand name "Galantamine" or generic name "Galantamine"

NDCBrand NameGeneric Name
0054-0090GalantamineGalantamine
0054-0091GalantamineGalantamine
0054-0092GalantamineGalantamine
0378-2721Galantaminegalantamine
0378-2722Galantaminegalantamine
0378-2723Galantaminegalantamine
0591-3496GalantamineGalantamine
0591-3497GalantamineGalantamine
0591-3498GalantamineGalantamine
0615-7541GalantamineGalantamine
0615-7542GalantamineGalantamine
0615-7543GalantamineGalantamine
0904-7104Galantaminegalantamine
51079-852Galantaminegalantamine
51079-853Galantaminegalantamine
57237-049GalantamineGalantamine
57237-050GalantamineGalantamine
68084-729GalantamineGalantamine
68382-177galantaminegalantamine
68382-178galantaminegalantamine
68382-179galantaminegalantamine
70436-005GalantamineGalantamine
70436-004GalantamineGalantamine
70436-006GalantamineGalantamine
57237-051GalantamineGalantamine
60505-2542GalantamineGalantamine
60505-2543GalantamineGalantamine
60505-2544GalantamineGalantamine
63739-708GalantamineGalantamine
63739-999GalantamineGalantamine
65862-458GalantamineGalantamine
65862-745GalantamineGalantamine
65841-755GalantamineGalantamine
65862-459GalantamineGalantamine
65862-460GalantamineGalantamine
65862-746GalantamineGalantamine
65841-756GalantamineGalantamine
65841-757GalantamineGalantamine
65862-744GalantamineGalantamine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.